Lung Cancer
Conference Coverage
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology
A pair of new studies show that drugs can reduce cancer risk when cells are elusive.
News
Widespread carboplatin, cisplatin shortages: NCCN survey
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
News
Safe to stop immunotherapy at 2 years in stable lung cancer
“These data may provide reassurance to us and patients that discontinuing treatment at 2 years can confer the same overall survival as extended...
Conference Coverage
SCLC: Bispecific antibody shows phase 1 promise
The antibody targets delta-like ligand 3, which is one of few surface markers for small cell lung cancer.
News
Warning on use of sotorasib after ICI in lung cancer
“We suggest avoiding starting sotorasib within 30 days from the last anti–PD-(L)1 infusion.”
News
Immunotherapy plus chemo improves quality of life in NSCLC
The delays reported in time to definitive clinically meaningful deterioration “are particularly pertinent, given the anticipated continued...
News
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
News
The breathtaking effects of climate change
“What we’re going to see is not just new diseases but also exacerbation of chronic diseases.”
News
Asthma tied to increased risk for multiple cancers
Treatment with an inhaled steroid may lower that risk, perhaps by keeping inflammation in check.
News
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.